139 related articles for article (PubMed ID: 22467227)
1. Prevalence and clinical outcomes of the 46/1 haplotype, Janus kinase 2 mutations, and ten-eleven translocation 2 mutations in Budd-Chiari syndrome and their impact on thrombotic complications post liver transplantation.
Westbrook RH; Lea NC; Mohamedali AM; Smith AE; Orr DW; Roberts LN; Heaton ND; Wendon JA; O'Grady JG; Heneghan MA; Mufti GJ
Liver Transpl; 2012 Jul; 18(7):819-27. PubMed ID: 22467227
[TBL] [Abstract][Full Text] [Related]
2. JAK2 V617F mutation and 46/1 haplotype in Chinese Budd-Chiari syndrome patients.
Wang H; Sun G; Zhang P; Zhang J; Gui E; Zu M; Jia E; Xu H; Xu L; Zhang J; Lu Z
J Gastroenterol Hepatol; 2014 Jan; 29(1):208-14. PubMed ID: 23980667
[TBL] [Abstract][Full Text] [Related]
3. Prevalence of the activating JAK2 tyrosine kinase mutation V617F in the Budd-Chiari syndrome.
Patel RK; Lea NC; Heneghan MA; Westwood NB; Milojkovic D; Thanigaikumar M; Yallop D; Arya R; Pagliuca A; Gäken J; Wendon J; Heaton ND; Mufti GJ
Gastroenterology; 2006 Jun; 130(7):2031-8. PubMed ID: 16762626
[TBL] [Abstract][Full Text] [Related]
4. Diagnostic value of the JAK2 V617F mutation for latent chronic myeloproliferative disorders in patients with Budd-Chiari syndrome and/or portal vein thrombosis.
Karaköse S; Oruç N; Zengin M; Akarca US; Ersöz G
Turk J Gastroenterol; 2015 Jan; 26(1):42-8. PubMed ID: 25698270
[TBL] [Abstract][Full Text] [Related]
5. Prevalence of JAK29V617F) mutation in intra-abdominal venous thrombosis.
Deepak A; Punamiya S; Patel N; Parekh S; Mehta S; Shah N
Trop Gastroenterol; 2011; 32(4):279-84. PubMed ID: 22696908
[TBL] [Abstract][Full Text] [Related]
6. Thrombotic risk factors in Chinese Budd-Chiari syndrome patients. An observational study with a systematic review of the literature.
Qi X; Wu F; Ren W; He C; Yin Z; Niu J; Bai M; Yang Z; Wu K; Fan D; Han G
Thromb Haemost; 2013 May; 109(5):878-84. PubMed ID: 23447059
[TBL] [Abstract][Full Text] [Related]
7. Occurrence of the JAK2 V617F mutation in the Budd-Chiari syndrome.
Colaizzo D; Amitrano L; Tiscia GL; Iannaccone L; Gallone A; Grandone E; Guardascione MA; Margaglione M
Blood Coagul Fibrinolysis; 2008 Jul; 19(5):459-62. PubMed ID: 18600100
[TBL] [Abstract][Full Text] [Related]
8. The impact of JAK2 and MPL mutations on diagnosis and prognosis of splanchnic vein thrombosis: a report on 241 cases.
Kiladjian JJ; Cervantes F; Leebeek FW; Marzac C; Cassinat B; Chevret S; Cazals-Hatem D; Plessier A; Garcia-Pagan JC; Darwish Murad S; Raffa S; Janssen HL; Gardin C; Cereja S; Tonetti C; Giraudier S; Condat B; Casadevall N; Fenaux P; Valla DC
Blood; 2008 May; 111(10):4922-9. PubMed ID: 18250227
[TBL] [Abstract][Full Text] [Related]
9. Prevalence of the JAK2V617F mutation in Chinese patients with Budd-Chiari syndrome and portal vein thrombosis: a prospective study.
Qi X; Zhang C; Han G; Zhang W; He C; Yin Z; Liu Z; Bai W; Li R; Bai M; Yang Z; Wu K; Fan D
J Gastroenterol Hepatol; 2012 Jun; 27(6):1036-43. PubMed ID: 22142461
[TBL] [Abstract][Full Text] [Related]
10. Meta-analysis: the significance of screening for JAK2V617F mutation in Budd-Chiari syndrome and portal venous system thrombosis.
Qi X; Yang Z; Bai M; Shi X; Han G; Fan D
Aliment Pharmacol Ther; 2011 May; 33(10):1087-103. PubMed ID: 21395632
[TBL] [Abstract][Full Text] [Related]
11. JAK2 mutations across a spectrum of venous thrombosis cases.
Shetty S; Kulkarni B; Pai N; Mukundan P; Kasatkar P; Ghosh K
Am J Clin Pathol; 2010 Jul; 134(1):82-5. PubMed ID: 20551270
[TBL] [Abstract][Full Text] [Related]
12. Hypereosinophilia, JAK2V617F, and Budd-Chiari syndrome: who is responsible for what?
Mishchenko E; Tadmor T; Schiff E; Attias D; Polliack A
Am J Hematol; 2011 Feb; 86(2):223-4. PubMed ID: 21264914
[TBL] [Abstract][Full Text] [Related]
13. The JAK2(V617F) tyrosine kinase mutation identifies clinically latent myeloproliferative disorders in patients presenting with hepatic or portal vein thrombosis.
Goulding C; Uttenthal B; Foroni L; Duke V; Traore A; Kottaridis P; Hoffbrand AV; Patch D; McNamara C
Int J Lab Hematol; 2008 Oct; 30(5):415-9. PubMed ID: 19046316
[TBL] [Abstract][Full Text] [Related]
14. JAK2V617F and prothrombin G20210A gene mutations in a patient with Budd-Chiari syndrome and essential thrombocythemia.
Musallam KM; Aoun EG; Mahfouz RA; Khalife M; Taher AT
Clin Appl Thromb Hemost; 2010 Aug; 16(4):472-4. PubMed ID: 19223280
[TBL] [Abstract][Full Text] [Related]
15. [Budd-Chiari syndrome and splanchnic vein thrombosis: masked myeloproliferative neoplasms and JAK2V617F].
Fama A; Rago A; Gioiosa F; Marzano C; Latagliata R; Mammì C; Laganà C; D'Elia GM; Bizzoni L; Trasarti S; Ferretti A; Breccia M; Riggio O; Tafuri A
Clin Ter; 2010; 161(2):169-71. PubMed ID: 20499034
[TBL] [Abstract][Full Text] [Related]
16. The presence of JAK2V617F mutation in the liver endothelial cells of patients with Budd-Chiari syndrome.
Sozer S; Fiel MI; Schiano T; Xu M; Mascarenhas J; Hoffman R
Blood; 2009 May; 113(21):5246-9. PubMed ID: 19293426
[TBL] [Abstract][Full Text] [Related]
17. Granulocyte whole exome sequencing and endothelial JAK2V617F in patients with JAK2V617F positive Budd-Chiari Syndrome without myeloproliferative neoplasm.
Helman R; Pereira WO; Marti LC; Campregher PV; Puga RD; Hamerschlak N; Chiattone CS; Santos FPS
Br J Haematol; 2018 Feb; 180(3):443-445. PubMed ID: 27650062
[No Abstract] [Full Text] [Related]
18. Association of factor V Leiden, Janus kinase 2, prothrombin, and MTHFR mutations with primary Budd-Chiari syndrome in Egyptian patients.
El Sebay HM; Safan MA; Daoud AA; Tayel SI; Nouh MA; El Shafie S
J Gastroenterol Hepatol; 2016 Jan; 31(1):235-40. PubMed ID: 26238013
[TBL] [Abstract][Full Text] [Related]
19. Myeloproliferative neoplasms in Budd-Chiari syndrome and portal vein thrombosis: a meta-analysis.
Smalberg JH; Arends LR; Valla DC; Kiladjian JJ; Janssen HL; Leebeek FW
Blood; 2012 Dec; 120(25):4921-8. PubMed ID: 23043069
[TBL] [Abstract][Full Text] [Related]
20. Role of the JAK2 mutation in the diagnosis of chronic myeloproliferative disorders in splanchnic vein thrombosis.
Primignani M; Barosi G; Bergamaschi G; Gianelli U; Fabris F; Reati R; Dell'Era A; Bucciarelli P; Mannucci PM
Hepatology; 2006 Dec; 44(6):1528-34. PubMed ID: 17133457
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
